A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Dr Venetia Bigley; Sarah Pagan; Brie Turner; Professor Graham Jackson; Professor Anne Dickinson; Professor Matthew Collin

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation. Lookup NU author(s) Dr Venetia Bigley Sarah Pagan Brie Turner Professor Graham Jackson Professor Anne Dickinson Professor Matthew Collin



Author(s)		Charlton A, Spence L, Bigley V, Groves N, Hale G, Pagan S, Turner BE, Jones G, Jackson GH, Dickinson AM, Collin M
Editor(s)
Publication type		Conference Proceedings (inc. Abstract)
Conference Name		Blood: 51st Annual Meeting of the American Society of Hematology
Conference Location		New Orleans, LA
Year of Conference		2009
Date		5-8 December 2009
Volume		114, 22
Pages		1293

ISBN




Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		American Society of Hematology

Actions
Library holdings		Search Newcastle University Library for this item